Hemorrhoids
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with grade I, II, III, and IV internal hemorrhoids accompanied by bleeding or prolapse; 2. Gender not limited, age between 18-100 years old; 3. Patients and their families understand and agree to participate in this study, and provide written informed consent to undergo sedation, analgesia/anesthesia, colonoscopy, and endoscopic hemorrhoid treatment.
Exclusion criteria
Exclusion criteria: 1. Patients who have received instrument therapy, including ligation and injection therapy, or surgical treatment, including hemorrhoidectomy, stapler hemorrhoid fixation, or transanal hemorrhoid artery ligation, within 3 months before the experiment; 2. Patients with acute episode of trapped hemorrhoids and/or thrombosis; 3. Patients with acute anal inflammation, anal fissure, anal fistula, perianal abscess, inflammatory bowel disease, etc.; 4. Patients with colon cancer or other cancers affecting treatment; 5. Severe immune dysfunction; 6. History of pelvic radiotherapy; 7. Pregnant or lactating women; 8. Patients with severe liver and kidney function, cardiopulmonary function, coagulation dysfunction, or severe underlying diseases, unstable condition, and unable to tolerate endoscopic surgery; 9. Patients with severe immune dysfunction; A history of mental illness; 10. Patients with other clinical or laboratory conditions that researchers believe are not suitable to participate in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence rate;effectiveness; | — |
Secondary
| Measure | Time frame |
|---|---|
| quality of life;patient satisfaction; | — |
Countries
China
Contacts
The Sixth Affiliated Hospital, Sun Yat-sen University